Crest Nicholson (CRST) Posts Earnings Results

Share on StockTwits

Crest Nicholson (LON:CRST) posted its quarterly earnings results on Tuesday. The company reported GBX 23.80 ($0.32) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Crest Nicholson had a net margin of 17.08% and a return on equity of 27.35%.

Crest Nicholson traded up GBX 3 ($0.04), hitting GBX 427.80 ($5.70), during midday trading on Thursday, MarketBeat.com reports. 1,805,244 shares of the company traded hands, compared to its average volume of 1,510,000. Crest Nicholson has a twelve month low of GBX 466.81 ($6.22) and a twelve month high of GBX 648.50 ($8.63).

The business also recently declared a dividend, which will be paid on Friday, October 5th. Shareholders of record on Thursday, September 20th will be issued a dividend of GBX 11.20 ($0.15) per share. The ex-dividend date is Thursday, September 20th. This represents a yield of 2.62%.

Several equities analysts recently weighed in on the stock. Shore Capital reaffirmed a “buy” rating on shares of Crest Nicholson in a research report on Thursday, March 22nd. Numis Securities cut their price objective on shares of Crest Nicholson from GBX 595 ($7.92) to GBX 493 ($6.56) and set an “add” rating on the stock in a research report on Wednesday. JPMorgan Chase & Co. cut their price objective on shares of Crest Nicholson from GBX 550 ($7.32) to GBX 500 ($6.66) and set a “neutral” rating on the stock in a research report on Wednesday. Credit Suisse Group reaffirmed a “buy” rating and set a GBX 530 ($7.06) price objective on shares of Crest Nicholson in a research report on Tuesday. Finally, Peel Hunt lowered shares of Crest Nicholson to a “hold” rating and cut their price objective for the company from GBX 660 ($8.79) to GBX 520 ($6.92) in a research report on Wednesday, May 16th. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Crest Nicholson currently has an average rating of “Buy” and an average target price of GBX 567.44 ($7.55).

In other Crest Nicholson news, insider Stephen Stone sold 250,000 shares of the stock in a transaction that occurred on Wednesday, April 18th. The stock was sold at an average price of GBX 483 ($6.43), for a total transaction of £1,207,500 ($1,607,642.12). Also, insider Leslie Van de Walle purchased 12,000 shares of the stock in a transaction on Tuesday, June 12th. The shares were bought at an average price of GBX 421 ($5.61) per share, for a total transaction of £50,520 ($67,261.35).

About Crest Nicholson

Crest Nicholson Holdings plc engages in builds homes in the United Kingdom. It develops apartments, houses, regeneration schemes, and garden villages; and commercial properties. The company serves first-time buyers, families, and investors. Crest Nicholson Holdings plc was founded in 1963 and is headquartered in Chertsey, the United Kingdom.

Receive News & Ratings for Crest Nicholson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crest Nicholson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Axiom Price Reaches $0.0078 on Exchanges
Axiom Price Reaches $0.0078 on Exchanges
Starta Hits 24-Hour Trading Volume of $0.00
Starta Hits 24-Hour Trading Volume of $0.00
Zacks: Brokerages Expect MTS Systems Co.  Will Announce Earnings of $0.63 Per Share
Zacks: Brokerages Expect MTS Systems Co. Will Announce Earnings of $0.63 Per Share
Obalon Therapeutics  Getting Somewhat Positive Media Coverage, Study Shows
Obalon Therapeutics Getting Somewhat Positive Media Coverage, Study Shows
Novus Therapeutics  Receives News Impact Score of 0.16
Novus Therapeutics Receives News Impact Score of 0.16
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc  This Quarter
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc This Quarter


Leave a Reply

 
© 2006-2018 Zolmax.